10x Genomics(TXG)今日盘前股价大跌近10%，引发了市场广泛关注。据报导,主要原因是川普政府削减了美国国立卫生研究院(NIH)的医疗研究经费。
消息显示,NIH上周末宣布,研究的间接费用资助额将限制在15%内,包括实验室、员工、基础设施和公用事业费用。这意味着去年90亿美元的"间接资金"将减少至50亿美元,大幅降低了全美大学和研究机构的医学和公共卫生研究支出。
作为基因测序设备供应商,10x Genomics的客户主要是医疗研究机构和大学实验室,NIH的拨款情况将直接影响其产品和服务的需求。据分析师估计,NIH间接拨款约占10x Genomics收入的20%。削减预算预计将对生命科学工具公司造成广泛不利影响,专业工具更受冲击。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.